First up is the ADEPT study in bullous pemphigoid (BP), a rare skin condition that leads to reddening of the skin and the formation of painful and intensely itchy chronic lesions and blisters ...

21, 2024 — Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global population and causes painful, recurring skin lesions and inflammation, primarily in the folds ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Identifying moles vs. skin cancer is not always easy. However, there are telltale signs that can help differentiate a benign (non-cancerous) skin lesion from potentially dangerous skin cancer. Benign ...

Autoimmune bullous diseases are often associated with ... Immunofluorescence (IMF) can demonstrate the presence of antibodies bound in the skin or antibodies circulating in the serum by showing ...

Biopsies and direct immunofluorescence confirmed the diagnosis of bullous pemphigoid (BP). BP is an autoimmune skin disorder in which autoantibodies bind to the dermal–epidermal junction. It is a rare ...

Sanofi has suggested the drug could become a $10 billion brand at its peak, if its use can be expanded further into areas like chronic obstructive pulmonary disease (COPD), bullous pemphigoid ...

a skin disease with underlying type 2 inflammation; regulatory submissions are under review in the U.S. and the Europ FDA decision expected by July 30, 2025TARRYTOWN, N.Y., Feb. 26, 2025 (GLOBE ...

Both smoking and obesity raise the risk of developing hidradenitis suppurativa. Possible symptoms associated with this type of rash include: Pus-filled bumps Hard pimple-like bumps beneath the skin ...

Most skin reactions are eczematous and allergic in nature, although urticarial, bullous, and vasculitic eruptions may occur. Also, more complex immune reactions may develop around the implants ...

Trujillo et al. identify scavenger receptor class B type I (SR-B1) as a keratinocyte marker of skin inflammation and a potential therapeutic target. Topically delivered HDL-like nanoparticles ...

Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...